Research Article
Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems
Table 5
Percentage cytotoxicity.
| | Samples | Well 1 | Well 2 | Well 3 | Well 4 | Well 5 | Well 6 |
| | 10 mg nanoparticles | 5.18 | −2.19 | 6.57 | 14.46 | 13.06 | 15.78 | | 10 mg IPB | 11.14 | 8.14 | 8.24 | −5.27 | 12.02 | 13.30 | | Cells only | — | — | — | — | — | — | | Fresh medium | — | — | — | — | — | — | | Empty wells | — | — | — | — | — | — |
|
|
